Moderna nabs funding to make vaccine against China coronavirus Jan. 23, 2020 9:41 AM ETModerna, Inc. (MRNA)By: Douglas W. House, SA News Editor6 Comments The Coalition for Epidemic Preparedness Innovations (CEPI), a public-private coalition aimed at accelerating the development of vaccines, has agreed to fund the manufacture of Moderna's (MRNA -1.8%) mRNA vaccine against the coronavirus causing the outbreak in China, named 2019-nCoV. NIH's National Institute of Allergy and Infectious Diseases (NIAID), Moderna's collaborator on the design of the vaccine, will conduct IND-enabling studies as well as a Phase 1 clinical trial.

@UncleSandro а вышло +238%

@ipmshik да сочно получилось, MRNA тогда еще не была в тренде:)